# A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women

> **NCT06219902** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 64 (actual)

## Conditions studied

- Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men
- Hot Flashes

## Interventions

- **DRUG:** Elinzanetant (BAY3427080)
- **DRUG:** Placebo to elinzanetant
- **DRUG:** Zopiclone
- **DRUG:** Placebo to zopiclone

## Key facts

- **NCT ID:** NCT06219902
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-08
- **Primary completion:** 2024-04-15
- **Final completion:** 2024-04-15
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2024-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06219902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06219902, "A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06219902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*